Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 17;59(7):1247-1255.
doi: 10.1515/cclm-2020-1669. Print 2021 Jun 25.

Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test

Lieve Van Hoovels  1   2 , Xavier Bossuyt  2   3 , Mariangela Manfredi  4 , Valentina Grossi  4 , Maurizio Benucci  5 , Stefanie Van Den Bremt  1 , Heidi De Baere  6 , Daria Franceschi  6 , Emiliano Tosi  6 , Marco Meoni  7 , Nicola Bizzaro  8 , Maria Infantino  4
Affiliations

Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test

Lieve Van Hoovels et al. Clin Chem Lab Med. .

Abstract

Objectives: Currently available computer-aided diagnosis (CAD) systems for the detection of anti-nuclear antibodies (ANA) by indirect immunofluorescence (IIF) assay enable a standardized measurement of system-specific fluorescent intensity (FI) measures. We aimed to evaluate an internal quality control (iQC) program that controls the total ANA IIF process in routine practice.

Methods: In addition to the kit iQC materials, supplemental quality indicators were integrated in a total quality assurance (QA) program: patient-derived iQC's samples (negative, 1/160 fine speckled and 1/160 homogeneous), median sample FI per run and percentage of ANA IIF positive samples per run. Analytical rejection criteria were based on the imprecision of the positivity index (PI) measure of the Zenit PRO system (Menarini). Clinical rejection criteria were based on changes in FI that correspond to a change in ANA IIF titer of ≥2. To evaluate the QA program, different artificial errors were introduced during the ANA IIF process. After every run, quality indicators were evaluated and compared to the pre-set target values.

Results: Rescanning the ANA IIF slides five times, using an old conjugate and a needle obstruction resulted in analytically and even clinically relevant errors in ANA IIF results. All errors were correctly detected by the different defined quality indicators. Traditional Westgard rules, including analytically (and clinically) defined rejection limits were useful in monitoring quality indicators.

Conclusions: The integration of a total process iQC program in CAD systems, based on the specific FI measurands and performance criteria of the system, adds value to QA.

Keywords: antinuclear antibodies; harmonization; indirect immunofluorescence; quality assurance.

PubMed Disclaimer

References

    1. Meroni, PL, Schur, PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420–2. https://doi.org/10.1136/ard.2009.127100.
    1. Damoiseaux, J, von Mühlen, CA, Garcia-De La Torre, I, Carballo, OG, de Melo Cruvinel, W, Francescantonio, PL, et al.. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights 2016;7:1. https://doi.org/10.1007/s13317-016-0075-0.
    1. Damoiseaux, J, Andrade, LEC, Carballo, OG, Conrad, K, Francescantonio, PLC, Fritzler, MJ, et al.. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis 2019;78:879–89. https://doi.org/10.1136/annrheumdis-2018-214436.
    1. Andrade, LEC, Klotz, W, Herold, M, Conrad, K, Rönnelid, J, Fritzler, MJ, et al.. International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I. Clin Chem Lab Med 2018;56:1783–8. https://doi.org/10.1515/cclm-2018-0188.
    1. Oyaert, M, Bossuyt, X, Ravelingien, I, Van Hoovels, L. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting. Clin Chem Lab Med 2016;54:e63–6. https://doi.org/10.1515/cclm-2015-0887.

Substances

LinkOut - more resources